Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06176729
What this trial is testing

Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Yan Zhang, MD 30
Testing effectiveness (Phase 2)Study completedNCT00039351
What this trial is testing

Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 32
Early research (Phase 1)Study completedNCT03492931
What this trial is testing

PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)

Who this might be right for
Sickle Cell Disease
AstraZeneca 21
Large-scale testing (Phase 3)Ended earlyNCT00766779
What this trial is testing

HCT Versus CT in Elderly AML

Who this might be right for
Acute Myeloid Leukemia
European Society for Blood and Marrow Transplantation 126
Post-approval studies (Phase 4)Study completedNCT01398540
What this trial is testing

Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine

Who this might be right for
Humoral and Cellular Immune Responses
Medical University of Vienna 60
Post-approval studies (Phase 4)Study completedNCT04077424
What this trial is testing

Senescent Immunity in Elders and Vaccine Responses (SILVER)

Who this might be right for
Flu Vaccine
Vanderbilt University Medical Center 10
Large-scale testing (Phase 3)Study completedNCT01767896
What this trial is testing

Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine

Who this might be right for
Influenza
UMN Pharma Inc. 1,020
Testing effectiveness (Phase 2)Study completedNCT02775903
What this trial is testing

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 213
Testing effectiveness (Phase 2)Study completedNCT03677154
What this trial is testing

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Hoffmann-La Roche 188
Testing effectiveness (Phase 2)Looking for participantsNCT06835803
What this trial is testing

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

Who this might be right for
Glioblastoma (GBM)
Brigham and Women's Hospital 56
Large-scale testing (Phase 3)Study completedNCT02215980
What this trial is testing

STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 210
Testing effectiveness (Phase 2)Study completedNCT00753714
What this trial is testing

Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 124
Not applicableUnknownNCT04836793
What this trial is testing

COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2

Who this might be right for
CancerElderlyHealthy Aging
Centre Hospitalier Universitaire de Besancon 300
Testing effectiveness (Phase 2)Study completedNCT01690507
What this trial is testing

Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML)

Who this might be right for
MDSAML
Chinese PLA General Hospital 29
Large-scale testing (Phase 3)Ended earlyNCT00135499
What this trial is testing

R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large-Cell, Diffuse
Lymphoma Study Association 138
Not applicableStudy completedNCT02438956
What this trial is testing

Oral Glutathione Supplementation in Older Healthy Adults and Its Effect on the Number of Healthy Days Experienced During Four Months of Supplementation Compared to Placebo

Who this might be right for
Improvement in Immune Cell Function in Elderly Humans
University of Florida 124
Large-scale testing (Phase 3)UnknownNCT04852705
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

Who this might be right for
COVID-19
Shenzhen Kangtai Biological Products Co., LTD 28,000
Large-scale testing (Phase 3)Study completedNCT01992107
What this trial is testing

Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

Who this might be right for
Influenza
Novartis Vaccines 2,333
Large-scale testing (Phase 3)Study completedNCT02344134
What this trial is testing

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 1,155
Testing effectiveness (Phase 2)Looking for participantsNCT06656598
What this trial is testing

Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

Who this might be right for
Stage III NSCLC
Intergroupe Francophone de Cancerologie Thoracique 152
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation